PLCB1 and central nervous system cancer: In addition, the results of the survival analysis carried out with the CGGA database indicated that patients with low- or high- grade glioma, characterized by a low expression of PLCβ1 have a shorter survival time in both primary and recurrent gliomas compared to patients with high-PLCβ1 expression (Fig. 1b).